This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

This week at the UPC: Nov. 21-27

By Charlotte Westphal and Inbar Preiss ( November 27, 2025, 16:35 GMT | Insight) -- The UPC clarified its test for inventive step this week, as the Court of Appeal restored Amgen’s cholesterol-related patent and upheld Edwards’ heart valve patent. The court also issued rulings on preliminary injunctions, partial revocation, costs, confidentiality and evidence-preservation across numerous cases.This week, the Unified Patent Court provided anticipated clarification on its approach to inventive step. The Court of Appeal restored Amgen’s cholesterol-lowering patent and used the case to spell out its test for obviousness, then applied the same standard to uphold Edwards’ heart-valve patent against Meril....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login